Clinical trial
Pioglitazone Study of Triglyceride Changes in Subjects With Type 2 Diabetes After Conversion From Rosiglitazone.
NCT00672919
Study timeline
Study start (unknown)2003-11-01Date precision: month
Registry last updated2012-02-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetes Mellitusunresolved
Interventions
PioglitazoneDRUG · verified · RxNorm: pioglitazone
Sponsors & collaborators
Takedalead sponsor
Mapped research locations
HoustonTexas, United States1MiamiFlorida, United States1San AntonioTexas, United States1NashvilleTennessee, United States1PittsburghPennsylvania, United States1BirminghamAlabama, United States1JacksonvilleFlorida, United States1OmahaNebraska, United States1TucsonArizona, United States1Winston-SalemNorth Carolina, United States1La JollaCalifornia, United States1Long BeachCalifornia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00672919 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.